NewAmsterdam Pharma Company N.V. Ordinary Shares

Stock Chart, Company Information, and Scan Results

$35.46(as of Feb 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

NewAmsterdam Pharma Company N.V. Ordinary Shares Company Information, Fundamentals, and Technical Indicators

Stock Price$35.46
Ticker SymbolNAMS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees100
CountyUSA
Market Cap$4,077.0M

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

NewAmsterdam Pharma Company N.V. Ordinary Shares In Our Stock Scanner

As of Mar 02, 2026
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.